Natural killer cell cytotoxity and course of illness in depressed mood.
There is now some evidence that depressed mood is associated with activation of the immune system. First, we evaluated, within a cross-sectional design, NKCA (in vitro) in 49 subjects meeting inclusion criteria either for a major depressive episode, for dysthymia, or for "double depression". We found that recent and long depressive episodes (dysthymia) are associated with a lower immunodepression. Second, we compared two subset of subjects: 14 patients meeting criteria of major depression to 14 healthy controls. The data show a significant improvement in major depression when compared to controls througout a treatment combining supportive psychotherapy and 8 mg Reboxetine™.
Université catholique de Louvain, Cliniques universitaires de Mont-Godinne, 5530 Yvoir, Belgium. Christine.reynaert@uclouvain.be
Christine
C
Reynaert
Pascal
P
Janne
Denis
D
Jacques
David
D
Tordeurs
Nicolas
N
Zdanowicz
D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use; D003430:Cross-Sectional Studies; D003601:Cytotoxicity Tests, Immunologic; D003865:Major Depressive Disorder / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology* / Q000523:psychology; D019263:Dysthymic Disorder / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology* / Q000523:psychology; D005260:Female; D006801:Humans; D007376:Interleukin-2 / Q000097:blood; D015850:Interleukin-6 / Q000097:blood; D020014:K562 Cells; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D009025:Morpholines / Q000627:therapeutic use; D010865:Pilot Projects; D000077593:Reboxetine; D055815:Young Adult
D000928:Antidepressive Agents; D007376:Interleukin-2; D015850:Interleukin-6; D009025:Morpholines; D000077593:Reboxetine